Efficacy and safety of tanezumab versus naproxen in the treatment of chronic low back pain. [electronic resource]
Producer: 20140124Description: 1009-21 p. digitalISSN:- 1872-6623
- Adolescent
- Adult
- Aged
- Analgesics -- therapeutic use
- Anti-Inflammatory Agents, Non-Steroidal -- therapeutic use
- Antibodies, Monoclonal, Humanized -- therapeutic use
- Chronic Pain -- drug therapy
- Double-Blind Method
- Drug-Related Side Effects and Adverse Reactions -- epidemiology
- Female
- Humans
- Low Back Pain -- drug therapy
- Male
- Middle Aged
- Naproxen -- therapeutic use
- Pain Measurement -- drug effects
- Placebo Effect
- Prevalence
- Risk Factors
- Treatment Outcome
- United States -- epidemiology
- Young Adult
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.